Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q80TR1

Entry ID Method Resolution Chain Position Source
2JX9 NMR - A 29-131 PDB
2JXA NMR - A 29-131 PDB
6SKA X-ray 386 A D 35-391 PDB
AF-Q80TR1-F1 Predicted AlphaFoldDB

65 variants for Q80TR1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388964613 6 A>V No EVA
rs3388964590 7 A>S No EVA
rs3388995520 45 P>L No EVA
rs3388995788 55 V>D No EVA
rs3388946928 98 N>K No EVA
rs3388992821 101 Q>H No EVA
rs3388964639 112 P>S No EVA
rs3399436775 204 N>D No EVA
rs3399344998 238 K>* No EVA
rs3398436706 238 K>M No EVA
rs864259211 350 E>D No EVA
rs3388995714 421 A>S No EVA
rs3388988364 493 L>M No EVA
rs3388995713 550 S>N No EVA
rs3388946871 557 R>W No EVA
rs3388992827 623 L>I No EVA
rs3388981761 641 H>P No EVA
rs3388988342 641 H>Q No EVA
rs3388995571 645 M>L No EVA
rs3388988341 662 R>K No EVA
rs3388988320 664 P>H No EVA
rs3388992770 672 Q>R No EVA
rs3388995547 679 T>N No EVA
rs3388993013 692 F>L No EVA
rs3388946897 692 F>S No EVA
rs3388992789 737 A>P No EVA
rs3388981778 746 G>R No EVA
rs3388976470 773 V>I No EVA
rs3388970770 788 A>P No EVA
rs3388988352 791 H>N No EVA
rs3389000448 804 R>G No EVA
rs3388995516 813 Q>H No EVA
rs3388976411 863 V>L No EVA
rs3388995702 864 I>N No EVA
rs3388995238 886 R>H No EVA
rs3388988310 887 N>D No EVA
rs3388987475 888 T>I No EVA
rs3388976458 900 A>V No EVA
rs3388987497 910 K>R No EVA
rs3399383020 929 L>Q No EVA
rs3399436726 936 C>S No EVA
rs3399383030 937 L>Q No EVA
rs3388976428 948 E>D No EVA
rs3398436687 976 A>V No EVA
rs3388995532 1002 I>V No EVA
rs3389000362 1010 V>M No EVA
rs3388976454 1019 T>A No EVA
rs3388988347 1030 L>F No EVA
rs3388976460 1034 S>C No EVA
rs3388946911 1048 I>S No EVA
rs3389000457 1052 F>V No EVA
rs3388995271 1093 A>V No EVA
rs3388970788 1115 S>F No EVA
rs3388987487 1117 P>S No EVA
rs3388946902 1119 G>D No EVA
rs3388970803 1124 L>P No EVA
rs3388995286 1145 R>G No EVA
rs3388995732 1187 P>H No EVA
rs3388993055 1211 V>I No EVA
rs3388993039 1214 S>Y No EVA
rs3388964587 1276 K>E No EVA
rs3389000461 1290 A>V No EVA
rs3388981756 1302 P>S No EVA
rs235934786 1339 P>S No EVA
rs3399554778 1447 P>T No EVA

No associated diseases with Q80TR1

2 regional properties for Q80TR1

Type Name Position InterPro Accession
domain Phospholipid/glycerol acyltransferase 180 - 309 IPR002123
domain 1-acyl-sn-glycerol-3-phosphate acyltransferase 181 - 306 IPR004552

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane; Multi-pass membrane protein
  • Cell projection, axon
  • Cell projection, growth cone
  • Synapse
  • Presynaptic cell membrane
  • Synapse, synaptosome
  • Colocalizes with TENM2 on the cell surface, across intercellular junctions and on nerve terminals near synaptic clefts
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

11 GO annotations of cellular component

Name Definition
anchoring junction A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix.
axon The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
glutamatergic synapse A synapse that uses glutamate as a neurotransmitter.
growth cone The migrating motile tip of a growing neuron projection, where actin accumulates, and the actin cytoskeleton is the most dynamic.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of presynaptic membrane The component of the presynaptic membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
neuron projection A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
postsynaptic density An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
presynaptic membrane A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

5 GO annotations of molecular function

Name Definition
carbohydrate binding Binding to a carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
cell adhesion molecule binding Binding to a cell adhesion molecule.
G protein-coupled receptor activity Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
latrotoxin receptor activity Combining with alpha-latrotoxin, a potent presynaptic neurotoxin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
toxic substance binding Binding to a toxic substance, a poisonous substance that causes damage to biological systems.

6 GO annotations of biological process

Name Definition
adenylate cyclase-activating G protein-coupled receptor signaling pathway A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity and a subsequent increase in the intracellular concentration of cyclic AMP (cAMP).
calcium-mediated signaling using intracellular calcium source The series of molecular signals in which a cell uses calcium ions released from an intracellular store to convert a signal into a response.
cell surface receptor signaling pathway The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell.
positive regulation of synapse assembly Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.
positive regulation of synapse maturation Any process that increases the extent of synapse maturation, the process that organizes a synapse so that it attains its fully functional state.

16 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q594P2 MYOC Myocilin Felis catus (Cat) (Felis silvestris catus) PR
Q25C36 OLFML3 Olfactomedin-like protein 3 Gallus gallus (Chicken) PR
Q9IAK4 OLFM1 Noelin Gallus gallus (Chicken) PR
O97148 mth G-protein coupled receptor Mth Drosophila melanogaster (Fruit fly) PR
Q9VSE7 mthl7 Probable G-protein coupled receptor Mth-like 7 Drosophila melanogaster (Fruit fly) PR
P83119 mthl12 Probable G-protein coupled receptor Mth-like 12 Drosophila melanogaster (Fruit fly) PR
Q99972 MYOC Myocilin Homo sapiens (Human) PR
Q99784 OLFM1 Noelin Homo sapiens (Human) PR
Q8IZF3 ADGRF4 Adhesion G protein-coupled receptor F4 Homo sapiens (Human) PR
Q9UHX3 ADGRE2 Adhesion G protein-coupled receptor E2 Homo sapiens (Human) PR
Q86SQ4 ADGRG6 Adhesion G-protein coupled receptor G6 Homo sapiens (Human) PR
O88998 Olfm1 Noelin Mus musculus (Mouse) PR
Q80ZF8 Adgrb3 Adhesion G protein-coupled receptor B3 Mus musculus (Mouse) PR
Q62609 Olfm1 Noelin Rattus norvegicus (Rat) PR
Q2Q426 ADGRE2 Adhesion G protein-coupled receptor E2 Macaca mulatta (Rhesus macaque) PR
A4IIT5 olfml2a Olfactomedin-like protein 2A Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MARLAAALWS LCVTTVLVTS ATQGLSRAGL PFGLMRRELA CEGYPIELRC PGSDVIMVEN
70 80 90 100 110 120
ANYGRTDDKI CDADPFQMEN VQCYLPDAFK IMSQRCNNRT QCVVVAGSDA FPDPCPGTYK
130 140 150 160 170 180
YLEVQYDCVP YIFVCPGTLQ KVLEPTSTHE SEHQSGAWCK DPLQAGDRIY VMPWIPYRTD
190 200 210 220 230 240
TLTEYASWED YVAARHTTTY RLPNRVDGTG FVVYDGAVFY NKERTRNIVK YDLRTRIKSG
250 260 270 280 290 300
ETVINTANYH DTSPYRWGGK TDIDLAVDEN GLWVIYATEG NNGRLVVSQL NPYTLRFEGT
310 320 330 340 350 360
WETGYDKRSA SNAFMVCGVL YVLRSVYVDD DSEAAGNRVD YAFNTNANRE EPVSLAFPNP
370 380 390 400 410 420
YQFVSSVDYN PRDNQLYVWN NYFVVRYSLE FGPPDPSAGP ATSPPLSTTT TARPTPLTST
430 440 450 460 470 480
ASPAATTPLR RAPLTTHPVG AINQLGPDLP PATAPAPSTR RPPAPNLHVS PELFCEPREV
490 500 510 520 530 540
RRVQWPATQQ GMLVERPCPK GTRGIASFQC LPALGLWNPR GPDLSNCTSP WVNQVAQKIK
550 560 570 580 590 600
SGENAANIAS ELARHTRGSI YAGDVSSSVK LMEQLLDILD AQLQALRPIE RESAGKNYNK
610 620 630 640 650 660
MHKRERTCKD YIKAVVETVD NLLRPEALES WKDMNATEQV HTATMLLDVL EEGAFLLADN
670 680 690 700 710 720
VREPARFLAA KQNVVLEVTV LNTEGQVQEL VFPQEYPSEN SIQLSANTIK QNSRNGVVKV
730 740 750 760 770 780
VFILYNNLGL FLSTENATVK LAGEAGTGGP GGASLVVNSQ VIAASINKES SRVFLMDPVI
790 800 810 820 830 840
FTVAHLEAKN HFNANCSFWN YSERSMLGYW STQGCRLVES NKTHTTCACS HLTNFAVLMA
850 860 870 880 890 900
HREIYQGRIN ELLLSVITWV GIVISLVCLA ICISTFCFLR GLQTDRNTIH KNLCINLFLA
910 920 930 940 950 960
ELLFLVGIDK TQYEVACPIF AGLLHYFFLA AFSWLCLEGV HLYLLLVEVF ESEYSRTKYY
970 980 990 1000 1010 1020
YLGGYCFPAL VVGIAAAIDY RSYGTEKACW LRVDNYFIWS FIGPVSFVIV VNLVFLMVTL
1030 1040 1050 1060 1070 1080
HKMIRSSSVL KPDSSRLDNI KSWALGAIAL LFLLGLTWAF GLLFINKESV VMAYLFTTFN
1090 1100 1110 1120 1130 1140
AFQGVFIFVF HCALQKKVHK EYSKCLRHSY CCIRSPPGGT HGSLKTSAMR SNTRYYTGTQ
1150 1160 1170 1180 1190 1200
SRIRRMWNDT VRKQTESSFM AGDINSTPTL NRGTMGNHLL TNPVLQPRGG TSPYNTLIAE
1210 1220 1230 1240 1250 1260
SVGFNPSSPP VFNSPGSYRE PKHPLGGREA CGMDTLPLNG NFNNSYSLRS GDFPPGDGGP
1270 1280 1290 1300 1310 1320
EPPRGRNLAD AAAFEKMIIS ELVHNNLRGA SGGAKGPPPE PPVPPVPGVS EDEAGGPGSA
1330 1340 1350 1360 1370 1380
DRAEIELLYK ALEEPLLLPR AQSVLYQSDL DESESCTAED GATSRPLSSP PGRDSLYASG
1390 1400 1410 1420 1430 1440
ANLRDSPSYP DSSPEGPNEA LPPPPPAPPG PPEIYYTSRP PALVARNPLQ GYYQVRRPSH
1450 1460
EGYLAAPSLE GPGPDGDGQM QLVTSL